Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero

Current Opinion in Neurology

Volumn 22, Issue 2, 2009, Pages 162-166

  Bromley, Rebecca L ^a   Baker, Gus A ^a,c   Meador, Kimford J ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Clinical Sciences Centre for Research and Education   (United Kingdom)

Author keywords

Antiepileptic drugs; Cognitive; Epilepsy; In utero; Pregnancy

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANTICONVULSANT THERAPY; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CHILD BEHAVIOR; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG EXPOSURE; DRUG RESEARCH; DRUG SAFETY; EPILEPSY; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE; LANGUAGE DISABILITY; METHODOLOGY; MONOTHERAPY; MOTOR DYSFUNCTION; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERATOGENICITY; CHEMICALLY INDUCED DISORDER; CHILD; CONGENITAL MALFORMATION; DRUG EFFECT; FEMALE; PREGNANCY;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; CHILD; CHILD BEHAVIOR; COGNITION; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 68849086999     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283292401     Document Type: Review

References (41)

1. Baker BL, McIntyre LL, Blacher I, et al. Pre-school children with and without developmental delay: behaviour problems and parental stress over time. J Intellect Disabil Res 2003; 47:217-230.
2. Emerson E. Mothers of children and adolescents with intellectual disability: social and economic situation, mental health status and the self-assessed social and psychological impact of the child's difficulties. J Intellect Disabil Res 2003; 47:385-399.
3. Dessens AB, Cohen-Kettenis P, Mellenbergh G, et al. Prenatal exposure to anticonvulsant drugs and spatial ability in adulthood. Acta Neurobiol Exp 1998; 58:221-225.
4. Vanoverloop D, Schnell RR, Harvey EA, Holmes LB. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 1992; 14:329-335
5. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, et al. Association of prenatal phenobarbital and phenytoin exposure with small head size at birth and with learning problems. Acta Paediatr 2000; 89:533-541.
6. Reinisch JM, Sanders S, Mortensen EL, Rubin DB. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995; 274:1518-1525.
7. Wide K, Winbladh B, Sars-Zimmer K, Berggren E. Psychomotor development minor anomalies in children exposed to antiepileptic drugs in utero: a prospective population-based study. Dev Med Child Neurol 2000; 42:87-92.
8. Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1976; 1:272-275.
9. Hill RM, Verniaud WM, Horning MG, et al. Infants exposed in utero to antiepileptic drugs. Am J Dis Child 1974; 127:645-653.
10. Hill RM, Verniaud WM, Rettig GM, et al. Relationship between antiepileptic drug exposure of the infant and developmental potential. In: Dea Janz, editor. Epilepsy, Pregnancy and the Child. New York: Ravens Press; 1982. pp. 409-417.
11. van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BCL. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol 1991; 164:121-128.
12. Parisi P, Francia A, Vanacore N, et al. Psychomotor development and general movements in offspring of women with epilepsy and anticonvulsant therapy. Early Hum Dev 2003; 74:97-108.
13. Rovet J, Cole S, Nulman I, et al. Effects of maternal epilepsy on children's neurodevelopment. Neuropsychology 1995; 1:150-157.
14. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271:767-770.
15. Ventosa L, Rocha L, Lourenco L, et al. Effects of epilepsy and antiepileptic drugs in children of mothers with epilepsy. Epilepsia 2002; 43:511.
16. Holmes LB, Coull BA, Dorfman J, Rosenberger PB. The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in-utero to anticonvulsant drugs. J Pediatr 2005; 146:118-122.
17. Vinten J, Adab N, Kini U, et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 2005; 64:949-954.
18. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75:1575-1583.
19. Dean JCS, Hailey H, Moore SJ, et al. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002; 39:251-259.
20. Gaily E, Kantola-Sorsa E, Hiilesmaa V, et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 2004; 62: 28-32.
21. Mawer G, Clayton-Smith J, Coyle H, Kini U. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure 2002; 11:512-518.
22. Kini U, Adab N, Vinten J, et al. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 2006; 91:F90-F95.
23. Adab N, Vinten J, Kini U. The longer-term effects of antiepileptic drug exposure in utero. Epilepsia 2002; 43:512.
24. Eriksson K, Viinikainen K, Monkkonen A, et al. Children exposed to valproate in utero - population based evidence of risks and confounding factors for long-term neurocognivite development. Epilepsy Res 2005; 65:189-200.
25. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001; 70:15-21.
26. Ornoy A, Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child 1996; 75:517-520.
27. Lyons Jones K, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320:1661-1666.
28. Wide K, Winbladh B, Kallen B. Major congenital malformations after intrauterine exposure to antiepileptic drugs especially carbamazepine and valproic acid. Epilepsia 2002; 43:513.
29. Thomas SV, Ajaykuma B, Indhu K, et al. Motor and mental development of --infants exposed to antiepileptic drugs in utero. Epilepsy Behav 2008; 13: 229-236.
30. Meador KJ, Baker GA, Browning N, et al. Neurodevelopmental effects of fetal --antiepileptic drug exposure. N Engl J Med (in press).
31. Meador KJ, Baker GA, Browning N, et al. Neurodevelopmental effects of fetal antiepileptic drug exposure: 3 year old cognitive outcomes. Epilepsia 2008; 49 (s7):490.
32. Kantola-Sorsa E, Gaily E, Isoaho M, Korkman M. Neuropsychological out--comes in children of mothers with epilepsy. J Int Neuropsychol Soc 2007; 13:642-652.
33. Titze K, Koch S, Helge H, et al. Prenatal and family risks of children born to --mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 2008; 50:117-122.
34. Steinhausen HC, Losche G, Koch S, Helge H. The psychological development of children of epileptic parents. I: Study design and comparative ?ndings. Acta Paediatr 1994; 83:955-960.
35. Moore SJ, Turnpenny PD, Quinn A, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000; 37:489-497.
36. Rasalam AD, Hailey H, Williams JH, et al. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005; 47:551-555.
37. Williams G, King J, Cunningham M, et al. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001; 43:202-206.
38. Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr 2005; 94:2-15.
39. Viinikainen K, Eriksson K, Monkkonen A, et al. The effects of valproate exposure in utero on behaviour and the need for educational support in school-aged children. Epilepsy Behav 2006; 9:636-640.
40. Bromley RL, Mawer G, Clayton-Smith J, Baker GA, On Behalf of the Liverpool--and Manchester Neurodevelopment Group. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008; 71: 1923-1924.
41. Nicolai J, Vles JS, Aldenkamp AP. Neurodevelopmental delay in children --exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias. J Neurol Sci 2008; 271:1-14.